Skip to main content
. 2013 Apr 30;2013(4):CD003552. doi: 10.1002/14651858.CD003552.pub4

2.1. Analysis.

2.1

Comparison 2 Skin patches containing norelgestromin + EE versus COC norgestimate 250 µg + EE 35 µg, Outcome 1 Discontinuation ‐ overall (cycle 4): patch NGMN 150 µg + EE 20 µg versus OC.